Enriched physical environment reverses spatial cognitive impairment of socially isolated APPswe/PS1dE9 transgenic mice before amyloidosis onset. 2018

Min Cao, and Pan-Pan Hu, and Yan-Li Zhang, and Yi-Xin Yan, and Christopher B Shields, and Yi-Ping Zhang, and Gang Hu, and Ming Xiao
Jiangsu Key Laboratory of Neurodegeneration, Nanjing Medical University, Nanjing, China.

Social isolation increases the onset of Alzheimer's disease (AD). Environmental enrichment, a complicated social and physical construct, plays beneficial effects on brain plasticity and function. This study was designed to determine whether physical enrichment can reduce the deleterious consequences of social isolation on the onset of AD. One-month-old APPswe/PS1dE9 transgenic AD model mice were singly housed in the enriched physical environment for 8 weeks and then received behavioral tests, neuropathological analyses, and Western blot of the hippocampus. The enriched physical environment reversed spatial cognitive decline of socially isolated APPswe/PS1dE9 mice. The functional reversal was associated with decreases in cellular apoptosis, synaptic protein loss, inflammation, and glial activation in the hippocampus, without changes in amyloid β neuropathology. These results suggest that the enriched physical environment may serve as a nonpharmacological intervention for delaying the onset of AD accompanied with social isolation.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008297 Male Males
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004777 Environment The external elements and conditions which surround, influence, and affect the life and development of an organism or population. Environmental Impact,Environmental Impacts,Impact, Environmental,Impacts, Environmental,Environments
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012934 Social Isolation The separation of individuals or groups resulting in the lack of or minimizing of social contact and/or communication. This separation may be accomplished by physical separation, by social barriers and by psychological mechanisms. In the latter, there may be interaction but no real communication. Isolation, Social,Social Exclusion,Exclusion, Social,Social Exclusions

Related Publications

Min Cao, and Pan-Pan Hu, and Yan-Li Zhang, and Yi-Xin Yan, and Christopher B Shields, and Yi-Ping Zhang, and Gang Hu, and Ming Xiao
March 2008, Neurobiology of aging,
Min Cao, and Pan-Pan Hu, and Yan-Li Zhang, and Yi-Xin Yan, and Christopher B Shields, and Yi-Ping Zhang, and Gang Hu, and Ming Xiao
December 2018, The international journal of neuropsychopharmacology,
Min Cao, and Pan-Pan Hu, and Yan-Li Zhang, and Yi-Xin Yan, and Christopher B Shields, and Yi-Ping Zhang, and Gang Hu, and Ming Xiao
June 2012, Sheng li ke xue jin zhan [Progress in physiology],
Min Cao, and Pan-Pan Hu, and Yan-Li Zhang, and Yi-Xin Yan, and Christopher B Shields, and Yi-Ping Zhang, and Gang Hu, and Ming Xiao
September 2016, Neuropharmacology,
Min Cao, and Pan-Pan Hu, and Yan-Li Zhang, and Yi-Xin Yan, and Christopher B Shields, and Yi-Ping Zhang, and Gang Hu, and Ming Xiao
January 2015, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Min Cao, and Pan-Pan Hu, and Yan-Li Zhang, and Yi-Xin Yan, and Christopher B Shields, and Yi-Ping Zhang, and Gang Hu, and Ming Xiao
June 2016, Journal of biomedical science,
Min Cao, and Pan-Pan Hu, and Yan-Li Zhang, and Yi-Xin Yan, and Christopher B Shields, and Yi-Ping Zhang, and Gang Hu, and Ming Xiao
January 2013, Neurobiology of aging,
Min Cao, and Pan-Pan Hu, and Yan-Li Zhang, and Yi-Xin Yan, and Christopher B Shields, and Yi-Ping Zhang, and Gang Hu, and Ming Xiao
November 2007, Neuroreport,
Min Cao, and Pan-Pan Hu, and Yan-Li Zhang, and Yi-Xin Yan, and Christopher B Shields, and Yi-Ping Zhang, and Gang Hu, and Ming Xiao
March 2013, Behavioural brain research,
Min Cao, and Pan-Pan Hu, and Yan-Li Zhang, and Yi-Xin Yan, and Christopher B Shields, and Yi-Ping Zhang, and Gang Hu, and Ming Xiao
March 2017, Molecular neurobiology,
Copied contents to your clipboard!